Bayerische Motoren Werke ADR (BMWYY)

Dallas, TX - August 6, 2025 - Dallas has a new destination for European auto enthusiasts who demand more from their repair, detailing, and performance experience. GB Motors, located at 11444 N Stemmons Fwy, is now open and raising the bar for European car care across the Dallas–Fort Worth metroplex.

HeartBeam (NASDAQ: BEAT), a cardiac technology company, has secured two new U.S. patents that significantly enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology ( https://ibn.fm/6xni4 ). The company, focused on delivering powerful, personalized insights into heart health through its innovative 3D ECG platform, now holds more than 20 U.S. and international patents, with additional applications pending.

On average, diabetics tend to suffer from depression at higher rates than is seen in the general population. A new study conducted by a team at the German Diabetes Center and other institutions in Germany has found that the markers of chronic inflammation influence how successful the treatments provided for depression will be for patients living with diabetes.

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases such as ALS and MS, announced that its management will present at the Canaccord 45th Annual Growth Conference and participate in one-on-one investor meetings.

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) emphasized the global trends driving demand for advanced breast cancer imaging technologies and the advantages of its IzoView Breast CT Imaging System. With over 2.3 million new cases of breast cancer diagnosed worldwide annually and U.S. incidence projected to exceed 315,000 in 2025, healthcare systems face growing pressure to improve screening outcomes. Market forecasts show global breast imaging revenues rising from $5.4 billion in 2024 to $8.69 billion by 2030. IzoView addresses clinical and patient needs with non-compressive 3D imaging, offering a more comfortable, accurate, and scalable alternative to conventional modalities—especially for the 50% of women with dense breast tissue.

Obtaining approval from the U.S. Food and Drug Administration (“FDA”) is a monumental achievement for any biopharmaceutical company, serving as a critical validation of a drug’s safety and efficacy. This rigorous process is a cornerstone of public health, ensuring that only treatments proven to be beneficial and with acceptable risks reach patients. Recognizing the immense value this milestone represents, Nutriband (NASDAQ: NTRB) recently underscored its commitment to this pathway by announcing a 25% preferred stock dividend as the company targets filing for FDA approval for its lead product, AVERSA(TM) Fentanyl ( https://ibn.fm/8FRUA ).

Mordor Intelligence has published a new report on the Luxury EV Market offering a comprehensive analysis of trends, growth drivers, and future projections

Irvine, Calif. – Modern Elite Transportation, a trusted name in executive ground travel since 2010, has launched a redesigned website that reflects its growing role as a mobility partner to professionals, event organizers, and institutions requiring precision and discretion. With operations centered in Southern California and now expanding globally, the company continues to embody its mission: Moving Those Who Move the World .

Researchers at the University of Kentucky have identified a key genetic biomarker that treatment teams could rely on to predict which patients having glioblastoma stand higher chances of benefiting from bevacizumab, a cancer drug.

BMW Group commenced its San Luis Potosí plant expansion in Mexico, with Jilian Group serving as the lead electromechanical engineering contractor. The expansion project in Mexico recently held its groundbreaking ceremony. Senior executives from Jilian joined BMW Mexico’s management team in witnessing this strategic milestone.

Computer scientists have designed an AI-based speech screening tool that could help people ascertain whether they could be exhibiting signs of Parkinson’s . The research explaining this speech tool appeared in the npj Parkinson’s Disease journal.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, will hold a conference call Aug. 13, 2025, at 4:30 p.m. Eastern to discuss second-quarter results for the period ended June 30, 2025. The company will also provide updates on regulatory initiatives, commercial-readiness activities and anticipated milestones. CEO Robert Eno and CFO Timothy Cruickshank will host the call, followed by a question-and-answer session.

Izotropic (CSE: IZO) (OTCQB: IZOZF) is a medical device company advancing dedicated imaging solutions to improve the screening, diagnosis, and treatment of breast cancer. Focused exclusively on this clinical area, Izotropic is developing purpose-built technologies designed to address persistent limitations in conventional breast imaging. Through innovation in both device architecture and image acquisition, the company aims to enhance diagnostic confidence while improving patient experience.

For years, oncologists have been baffled by why checkpoint inhibitors work for some cancer patients and not others. This challenge has made it difficult for these immunotherapies to be widely used since it isn’t easy to predict who will benefit and yet the treatments are currently very expensive .

Las Vegas, Nevada - SmartTOP manufacturer Mods4cars has announced a permanent price reduction for its SmartTOP convertible top control module for Volkswagen Beetle Convertible. The retrofittable SmartTOP module is now available for 149.00 Euros plus tax. “We’re pleased that even more VW Beetle drivers can now enjoy the benefits of our feature-rich upgrade,” says PR spokesperson Sven Tornow.

Libertyville, IL () July 28, 2025 -- Expert BMW maintenance at Auto Lab Libertyville redefines luxury vehicle care for local drivers

HealthLynked (OTCQB: HLYK), a pioneer in healthcare technology and patient engagement, announced the launch of its newly designed Enterprise Healthcare Solutions Website, www.hlykgroup.com , and significant enhancements to its national provider directory. The new platform serves as a centralized hub for insurance carriers, pharmaceutical companies, marketing firms, ACOs, healthcare networks, and large employers, offering tools for patient engagement, population health, clinical research, coordinated care, and cost management. Upgrades to the consumer-facing provider directory include faster performance and localized provider suggestions, giving patients improved flexibility and transparency in selecting care. CEO Dr. Michael Dent said the developments reflect HealthLynked’s expanding role in the healthcare ecosystem and its commitment to scalable solutions that improve outcomes and reduce costs.

Nutriband (NASDAQ: NTRB) is positioning at the forefront of abuse-deterrent drug delivery in advancing its flagship fentanyl patch and buprenorphine candidates. The company combines transdermal innovation with abuse-deterrent science to meet critical public health needs. According to Nurtiband, AVERSA Fentanyl, with the possibility to reach peak annual U.S. sales of $80 to $200 million, holds the potential to be the world’s first opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. In addition, Nutriband is advancing AVERSA Buprenorphine, which upon approval is projected to achieve peak U.S. sales between $70 and $130 million. Both candidates benefit from Nutriband’s scalable platform, and the technology is on track for global patent protection.

According to a new survey, approximately 60% of workers in the U.S. healthcare sector are concerned about their personal safety while at work and these concerns are prompting many to consider quitting their positions. This situation is concerning because the healthcare industry is already facing worker shortages and those who want to leave could worsen matters.

Oral mucositis, a debilitating side effect of cancer therapy with no FDA-approved treatment, continues to wreak havoc on patients undergoing cancer care, prompting an urgent need for effective interventions. Soligenix (NASDAQ: SNGX) is stepping forward with SGX942, a novel therapeutic aimed at alleviating this condition, with promising phase 3 data showing substantial improvements in the duration and severity of mucositis in head and neck cancer patients .

Latest UN data indicates that at least 14 million kids didn’t receive life-saving shots of vaccines against tetanus, whooping cough and diphtheria in 2024. This threatens the attainment of global vaccination goals.

Melbourne riders now have a dependable way to sell their damaged motorcycles and find affordable used parts, thanks to Motorbike Wreckers Melbourne. Specialising in road, enduro, and dirt bikes, the company offers fast cash deals, same-day pickup, and access to an extensive inventory of tested motorcycle parts. Customers across Victoria and wider Australia benefit from a smooth, stress-free experience whether buying or selling.

Motorbike Wreckers Adelaide has officially upgraded its wrecking and parts supply operations, making it easier than ever for riders across the region to sell old motorcycles or source affordable second-hand parts. With growing demand for sustainable motorbike recycling, the company is now expanding its inventory, speeding up its cash-for-bike process, and offering secure delivery services across Australia.

Motorbike Wreckers Perth is changing the way bike owners in Western Australia maintain and repair their motorcycles. Known for being one of the leading motorcycle wreckers Perth has to offer, the company is committed to providing reliable used parts, simple wrecking services, and competitive cash offers for unwanted bikes.

A team of researchers testing an experimental messenger RNA (mRNA) vaccine managed to ramp up the ability of immunotherapy to combat tumors in a study using mouse models. This finding potentially brings scientists one step closer to developing universal vaccines that can supercharge the immune system in its fight against cancer.